Relationship between IFN-alpha, IL-1B, IL-5, IL-6 and effectiveness of the first-line with camrelizumab combined with chemotherapy in non small cell lung cancer
机构：[1]Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang, Peoples R China临床科室肿瘤内科河北医科大学第四医院[2]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China河北医科大学第四医院[3]Hebei Med Univ, Dept Res Ctr, Hosp 4, Shjiazhuang, Peoples R China河北医科大学第四医院
第一作者机构：[1]Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang, Peoples R China
推荐引用方式(GB/T 7714)：
Shi Jian,Duan Xiaoyang,Liu Rongfeng,et al.Relationship between IFN-alpha, IL-1B, IL-5, IL-6 and effectiveness of the first-line with camrelizumab combined with chemotherapy in non small cell lung cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):doi:10.1200/JCO.2022.40.16_suppl.e21059.
APA：
Shi, Jian,Duan, Xiaoyang,Liu, Rongfeng,Wang, Zhen,Han, Shan&Shan, Baoen.(2022).Relationship between IFN-alpha, IL-1B, IL-5, IL-6 and effectiveness of the first-line with camrelizumab combined with chemotherapy in non small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Shi, Jian,et al."Relationship between IFN-alpha, IL-1B, IL-5, IL-6 and effectiveness of the first-line with camrelizumab combined with chemotherapy in non small cell lung cancer".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)
医学